Catalyst Wire Dossier Catalyst Wire Dossier

Alpha1 proteinase inhibitor

alpha-1 proteinase inhibitor · CSL Behring
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Alpha1 proteinase inhibitor, covering 2012-04-05 to 2020-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease [Phase 2, Phase 3]

See pricing